Skip to content

Clinical Study on the Treatment of Headache Based on Lingshu•Jvebing

Clinical Study on the Treatment of Headache Based on Lingshu•Jvebing

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400088588
Enrollment
Unknown
Registered
2024-08-21
Start date
2023-12-30
Completion date
Unknown
Last updated
2024-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Headache

Interventions

Experimental group:Treatment plan of headache in Lingshu Jvebing
Control group:The treatment plan of headache in the textbook of acupuncture and moxibustion

Sponsors

Nantong Third People'Hospital/Nantong Third Hospital Affiliated to Nantong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Meet the diagnostic criteria for migraine and tension headache in Western medicine, as well as for headache in Traditional Chinese medicine; (2) Age: 18-70 years old; (3) It is in the period of headache attack, and the VAS score is greater than 3 points; (4) Did not take preventive drugs for the 3 months before the treatment; (5) Be able to accept the treatment method of this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Patients with headache caused by cerebrovascular diseases, sequelae of brain trauma, and organic lesions in the brain; (2) Patients with severe primary diseases such as cardiovascular, liver, kidney and hematopoietic system and mental illness; (3) patients with infectious diseases; (4) Pregnant or lactating women.

Design outcomes

Primary

MeasureTime frame
Visual analog scale score (VAS);Headache symptom score;

Secondary

MeasureTime frame
Use of analgesic medication;

Countries

China

Contacts

Public ContactWang Tingting/ Wang Xinjun

Nanjing University of Traditional Chinese Medicine/ Nantong Third People'Hospital

nj_drwang@163.com+86 139 1387 0878

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026